本文選題：豬 + Hnrnpk��； 參考：《信陽師范學(xué)院》2015年碩士論文

【摘要】：核不均一核糖核蛋白k (heterogeneous nuclear ribonucleoprotein k, Hnrnpk)是一個多功能蛋白,參與DNA修復(fù)、轉(zhuǎn)錄和翻譯調(diào)控、RNA的剪切加工等生物學(xué)過程,能通過多種途徑對成肌細(xì)胞增殖與分化起重要調(diào)控作用,但其作用機(jī)制及信號通路尚不清楚。c-Src作為非受體蛋白酪氨酸激酶家族的一員,可以通過Rat/MEK/ERK和p38MAPK信號通路對骨骼肌肌生成過程起著重要的調(diào)節(jié)作用,但其在成肌細(xì)胞中的表達(dá)調(diào)控機(jī)制卻不清楚。以往研究表明Hnrnpk與c-Src存在多層次的互作并發(fā)揮重要生物學(xué)功能。本研究從豬Hnrnpk和c-Src基因的克隆及表達(dá)著手,以小鼠C2C12成肌細(xì)胞為模型,結(jié)合qRT-PCR、免疫印跡、細(xì)胞轉(zhuǎn)染、亞細(xì)胞定位、免疫熒光、過表達(dá)、RNA干涉、Co-IP、GST pull-down、酵母雙雜交、RIP等方法,深入探討Hnrnpk與c-Src的互作及其在C2C12成肌細(xì)胞增殖分化中的作用,這將為闡明骨骼肌發(fā)育和再生的復(fù)雜網(wǎng)絡(luò)調(diào)節(jié)機(jī)制奠定基礎(chǔ),而且還可望為畜牧業(yè)提高動物的產(chǎn)肉量、肉品質(zhì)及醫(yī)學(xué)上控制肌肉再生提供理論依據(jù)。本研究得到以下結(jié)果： 1. Hnrnpk基因的克隆及時空表達(dá)分析 克隆得到2056bp豬Hnrnpk基因的cDNA序列,包含1395bp的開放閱讀框,編碼464個氨基酸；Hnrnpk基因在梅山豬不同發(fā)育時期的背最長肌中均差異表達(dá),胚胎期表達(dá)量最高,并且隨著生長發(fā)育呈下調(diào)表達(dá)。Hnrnpk基因在120日齡的大白豬肌肉和脂肪組織中相對高表達(dá),腎、肺中次之,心、大腦、肝、脾和卵巢中的表達(dá)相對較低。而就四種不同類型肌肉組織而言,半腱肌和背最長肌中表達(dá)量最高,咬肌次之,股二頭肌中最低；Hnrnpk基因在C2C12細(xì)胞分化過程中表達(dá)下調(diào),其直接調(diào)控的c-myc、c-Src、p21等基因表達(dá)趨勢與之相似。 2. c-Src基因的克隆及時空表達(dá)分析 克隆得到4126bp豬c-Src基因的cDNA序列,包含1629bp的開放閱讀框,編碼542個氨基酸；c-Src基因在大白豬和梅山豬肌肉中的表達(dá)模式相似,均在胚胎65日齡高表達(dá),出生后3天表達(dá)量極顯著減少,而在21日齡又表達(dá)上調(diào),此后隨著發(fā)育逐漸下調(diào)；兩品種相比,胚胎65日齡,c-Src基因在梅山豬中的表達(dá)量顯著高于大白豬(P0.05),而出生后3天、21天及6月齡大白豬中的表達(dá)量均極顯著高于梅山豬(P0.01); c-Src基因在豬不同組織中廣泛表達(dá),在PT期,大腦中c-Src基因的表達(dá)量最高,肝臟中表達(dá)量最低。在3天,肝臟中c-Src基因的表達(dá)量最高,骨骼肌中表達(dá)量最低。在4月齡,肺中c-Src基因的表達(dá)量最高,骨骼肌中表達(dá)量最低；在C2C12細(xì)胞誘導(dǎo)分化過程中,c-Src基因隨著誘導(dǎo)分化表達(dá)先上調(diào)后逐漸下調(diào)。 3. Hnrnpk對C2C12細(xì)胞增殖分化的影響 超表達(dá)Hnrnpk基因后,成肌轉(zhuǎn)錄因子MyoG, Myf6的表達(dá)量下調(diào),而MyoD卻上調(diào),成熟骨骼肌相關(guān)分子標(biāo)記物MLC2、MCK、TAK1下調(diào),c-Src表達(dá)量上調(diào),p21下調(diào)；siRNA干涉Hnrnpk后,成肌轉(zhuǎn)錄因子MyoG、Myf6和MyoD以及成熟骨骼肌相關(guān)分子標(biāo)記物MLC2、 MCK表達(dá)量上調(diào),c-Src表達(dá)量下調(diào),p21上調(diào)。表明Hnrnpk可能通過上調(diào)c-Src和下調(diào)成肌轉(zhuǎn)錄因子MRFs家族的表達(dá)從而促進(jìn)C2C12細(xì)胞增殖或抑制分化。 4. c-Src對C2C12細(xì)胞增殖分化的影響 超表達(dá)c-Src基因后,成肌轉(zhuǎn)錄因子MyoG、 Myf6、 MyoD的表達(dá)量下調(diào),而且成熟骨骼肌相關(guān)分子標(biāo)記物MLC2、 MCK、 TAK1表達(dá)量下調(diào),p21表達(dá)量下調(diào)；PP2抑制劑處理C2C12細(xì)胞后,MyoG和MyoD分化標(biāo)記基因、p21、凋亡基因Caspase3表達(dá)量均上調(diào),p53和c-myc基因下調(diào)表達(dá),而c-Src表達(dá)沒有變化。表明c-Src對C2C12細(xì)胞增殖分化發(fā)揮作用可能是通過直接或間接調(diào)節(jié)成肌轉(zhuǎn)錄因子MRFs家族和p21的表達(dá)來實(shí)現(xiàn)的。 5.Hnrnpk與c-Src的互作分析 通過ELM在線分析發(fā)現(xiàn)與Hnrnpk相互作用的眾多元件包括了c-Src蛋白的SH3結(jié)構(gòu)域,進(jìn)而采用Co-IP初步證實(shí)內(nèi)源性的Hnrnpk和c-Src在分化的C2C12細(xì)胞中相互作用；此外,又用酵母雙雜交和GST pull-down方法對Hnrnpk與c-Src的互作進(jìn)一步分析,酵母雙雜交結(jié)果表明Hnrnpk與c-Src的全長以及單獨(dú)的SH3結(jié)構(gòu)域互作,與其他缺失體不互作,與c-Src全長的結(jié)合活性要強(qiáng)于單獨(dú)的SH3結(jié)構(gòu)域；GST pull-down結(jié)果表明Hnrnpk能夠在體外與c-Src的全長及所有缺失體相互作用。RIP實(shí)驗(yàn)結(jié)果表明分化的C2C12細(xì)胞中c-Src mRNA與Hnrnpk的結(jié)合能力要極顯著高于陰性對照IgG抗體(P0.01),而增殖的C2C12細(xì)胞中c-Src mRNA和Hnrnpk的結(jié)合能力與陰性對照IgG抗體相比差異不顯著(P0.05),表明Hnrnpk只在分化的C2C12細(xì)胞中與c-Src mRNA互作,這與鼠Hnrnpk在C2C12細(xì)胞中的亞細(xì)胞分布是一致的。
[Abstract]:The effects of Hnrnpk on the proliferation and differentiation of myoblasts were investigated by means of rat / MEK / ERK and p38MAPK signaling pathways .

Cloning and Expression Analysis of 1 . Hnrnpk Gene

The cDNA sequence of the 2056bp porcine Hnrnpk gene was cloned , and the cDNA sequence was 1395bp open reading frame , and 464 amino acids were encoded .
The expression of Hnrnpk gene in muscle and adipose tissue of 120 - day - old pig muscle and adipose tissue was the highest , and the expression of Hnrnpk gene in muscle and adipose tissue was relatively low .
The expression of Hnrnpk gene was down regulated in C2C12 cell differentiation , and its direct regulation of c - myc , c - myc , p21 and other genes were similar .

Cloning and Expression Analysis of the 2 . c - src Gene

the cDNA sequence of the 4126 bp porcine c - src gene was cloned , and a 1629 bp open reading frame was obtained , and 542 amino acids were encoded ;
the expression pattern of c - src gene in muscle of pig and meishan pig was similar , which was expressed at the age of 65 days of embryo , and the expression level was significantly decreased at the third day after birth , while the expression rate was up - regulated at the age of 21 , and then gradually decreased with development .
Compared with the two breeds , the expression of c - src gene was significantly higher in the pigs than that in Mishan ( P0.05 ) , while the expression of c - src gene was the highest in the three days after birth . The c - src gene expression was the highest in the liver and the lowest in skeletal muscle .
During the induction and differentiation of C2C12 cells , the c - src gene was down - regulated with the increase of induction differentiation .

3 . Effect of Hnrnpk on proliferation and differentiation of C2C12 cells

After overexpression of Hnrnpk gene , myogenic transcription factor MyoG , Myf6 expression was down - regulated , while MyoD was up - regulated , and the mature skeletal muscle - related molecular markers MLC2 , MCK , TAK1 were down - regulated , and the expression of c - src was up - regulated and p21 down - regulated ;
After interfering with Hnrnpk by siRNA , myogenic transcription factors , MyoG , Myf6 and MyoD , and mature skeletal muscle - related molecular markers MLC2 , MCK expression were up - regulated , and the expression of c - src was down - regulated , and p21 was up - regulated . It was suggested that Hnrnpk might promote the proliferation of C2C12 cells or inhibit differentiation by up - regulating the expression of c - src and down - regulating the MRFs family .

4 . Effects of c - src on the proliferation and differentiation of C2C12 cells

The expression of myogenic transcription factor MyoG , Myf6 , MyoD was down regulated after overexpression of c - src gene , and the expression of related molecular markers MLC2 , MCK , TAK1 of mature skeletal muscle was down regulated , and the expression level of p21 was down regulated .
After treatment of C2C12 cells , the expression of MyoG and MyoD differentiation marker gene , p21 and apoptosis gene Caspase3 were up - regulated , and the expression of p53 and c - myc was downregulated .

5 . Interaction between Hnrnpk and c - src

Many elements interacting with Hnrnpk were found by ELM on - line analysis , including the SH3 domain of c - src protein , and then Co - IP was used to demonstrate the interaction of endogenous Hnrnpk and c - src in differentiated C2C12 cells .
In addition , the interaction of Hnrnpk and c - src was further analyzed by yeast two - hybrid and GST pull - down methods . The results showed that Hnrnpk was the full - length of c - src and that of the isolated SH3 domains , which did not interact with other deletions , and the binding activity of the full length of c - src was stronger than that of the single SH3 domain ;
The results of RIP showed that Hnrnpk was significantly higher than that of negative control IgG antibody ( P0.01 ) , and the binding ability of c - src mRNA and Hnrnpk in C2C12 cells was significantly higher than that of negative control IgG antibody ( P0.05 ) .

【學(xué)位授予單位】：信陽師范學(xué)院
【學(xué)位級別】：碩士
【學(xué)位授予年份】：2015
【分類號】：S828

【共引文獻(xiàn)】

相關(guān)期刊論文 前10條

1 薛傳靜;劉新光;陳維春;;HnRNP A/B蛋白D亞群的生物學(xué)功能[J];中國生物化學(xué)與分子生物學(xué)報;2012年11期

2 李益婷;徐楊;蔡鎮(zhèn)西;張佳麗;劉佳;奚曉東;;整合素α_(Ⅱb)β_3信號轉(zhuǎn)導(dǎo)通路相關(guān)蛋白的研究進(jìn)展[J];上海交通大學(xué)學(xué)報(醫(yī)學(xué)版);2013年09期

3 R Mitchell Baldwin;Alan Morettin;Jocelyn C?té;;Role of PRMTs in cancer: Could minor isoforms be leaving a mark?[J];World Journal of Biological Chemistry;2014年02期

4 李發(fā)慧;王芳;王江云;;活細(xì)胞內(nèi)RNA標(biāo)記和成像技術(shù)[J];生命科學(xué);2014年03期

5 溫文婷;夏白雪;張佳娣;聶遠(yuǎn)洋;李璐;官久強(qiáng);羅曉林;孫群;;牦牛背最長肌蛋白質(zhì)雙向電泳條件的建立[J];食品科學(xué);2014年19期

6 Mario Angelo Pagano;Elena Tibaldi;Giorgio Palù;Anna Maria Brunati;;Viral proteins and Src family kinases: Mechanisms of pathogenicity from a “l(fā)iaison dangereuse”[J];World Journal of Virology;2013年02期

7 Odrick R.Rosas;Aranza I.Torrado;Jose M.Santiago;Ana E.Rodriguez;Iris K.Salgado;Jorge D.Miranda;;Long-term treatment with PP2 after spinal cord injury resulted in functional locomotor recovery and increased spared tissue[J];Neural Regeneration Research;2014年24期

8 范紅波;陳軍芳;許杰;肖嚴(yán);黃欣媛;;雙分子熒光互補(bǔ)技術(shù)在神經(jīng)系統(tǒng)變性疾病蛋白質(zhì)寡聚化研究中的應(yīng)用[J];現(xiàn)代生物醫(yī)學(xué)進(jìn)展;2015年02期

9 Iris K.Salgado;Aranza I.Torrado;Jose M.Santiago;Jorge D.Miranda;;Tamoxifen and Src kinase inhibitors as neuroprotective/neuroregenerative drugs after spinal cord injury[J];Neural Regeneration Research;2015年03期

10 韓星;丁欣;馮星;;RNA結(jié)合蛋白對神經(jīng)發(fā)育和神經(jīng)性疾病的影響[J];齊齊哈爾醫(yī)學(xué)院學(xué)報;2015年03期

相關(guān)會議論文 前1條

1 李發(fā)慧;王芳;王江云;;活細(xì)胞內(nèi)RNA標(biāo)記和成像技術(shù)[A];生命科學(xué)——專題：RNA研究的新技術(shù)和新方法（第26卷第3期）[C];2014年

相關(guān)博士學(xué)位論文 前10條

1 農(nóng)慧;川芎嗪促進(jìn)BK_（Ca）通道介導(dǎo)早期糖尿病大鼠血管平滑肌細(xì)胞凋亡的研究[D];廣州中醫(yī)藥大學(xué);2008年

2 王珊;精氨酸甲基化轉(zhuǎn)移酶1對神經(jīng)膠質(zhì)瘤細(xì)胞生長的影響及作用機(jī)制研究[D];北京協(xié)和醫(yī)學(xué)院;2012年

3 龔德順;人源RBM25蛋白的PWI結(jié)構(gòu)域及其鄰近堿性區(qū)域的結(jié)構(gòu)與功能研究[D];中國科學(xué)技術(shù)大學(xué);2013年

4 耿丹丹;EphB2對Aβ寡聚體誘導(dǎo)的神經(jīng)毒性損傷和NMDAR信號通路的保護(hù)作用[D];河北醫(yī)科大學(xué);2013年

5 陳利紅;二穗短柄草MAPK和MAPKK家族的鑒定、相互作用及其表達(dá)譜分析[D];華中科技大學(xué);2013年

6 楊金華;鼠冠狀病毒S蛋白膜內(nèi)區(qū)結(jié)構(gòu)與功能關(guān)系的研究[D];復(fù)旦大學(xué);2011年

7 張晶;新型疫苗佐劑—硫酸乙酰肝素刺激DCs后差異蛋白質(zhì)組學(xué)研究[D];北京協(xié)和醫(yī)學(xué)院;2013年

8 曹穎;HIV-1感染者Vpr基因多態(tài)性及其臨床意義研究[D];北京協(xié)和醫(yī)學(xué)院;2013年

9 肖銳;抑制SMN2外顯子7剪接的調(diào)控蛋白的鑒定和作用機(jī)制研究[D];武漢大學(xué);2012年

10 泰文嬌;番荔枝酰胺衍生物FLZ的神經(jīng)保護(hù)作用機(jī)制研究[D];北京協(xié)和醫(yī)學(xué)院;2013年

相關(guān)碩士學(xué)位論文 前10條

1 霍錦霞;家蠶squid基因的原核表達(dá)和定位分析[D];浙江理工大學(xué);2010年

2 韓軍;hnRNP A2/B1及p21~(WAF1)蛋白在非小細(xì)胞肺癌中表達(dá)及意義[D];安徽醫(yī)科大學(xué);2011年

3 韓峰;P62～（c-Yes）在人類肝癌和LEC大鼠肝組織中的表達(dá)[D];中國醫(yī)科大學(xué);2003年

4 刁薇;東方田鼠日本血吸蟲天然抗性相關(guān)基因的篩選和驗(yàn)證[D];中國疾病預(yù)防控制中心;2008年

5 錢曉慧;檢測血液及痰液中hnRNPA2/B1的表達(dá)在非小細(xì)胞肺癌診斷中的意義[D];南昌大學(xué);2012年

6 孫雪萍;JNK抑制劑及RNA干擾核仁素對U251細(xì)胞增殖與凋亡的影響研究[D];蘇州大學(xué);2013年

7 陳雪梅;家蠶核型多角體病毒ORF79基因（bm79）的結(jié)構(gòu)和蛋白互作分析[D];西南大學(xué);2013年

8 黃官禮;新生大鼠骨骼肌肌源性干細(xì)胞的分離、純化、培養(yǎng)和鑒定[D];河北醫(yī)科大學(xué);2013年

9 歐劍波;~(60)Co-γ射線誘導(dǎo)大鼠唾液腺細(xì)胞凋亡及NBS1蛋白表達(dá)的實(shí)驗(yàn)研究[D];廣西醫(yī)科大學(xué);2013年

10 韋瑋;甲基轉(zhuǎn)移酶抑制劑地西他濱對2型糖尿病小鼠能量代謝和胰島素傳導(dǎo)通路的影響[D];廣西醫(yī)科大學(xué);2013年

，

本文編號：1739028